Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model

Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy

(2015) Hayato Fujita et al.   NEOPLASIA

Dietary Energy Balance Modulates Epithelial-to-Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-like Mammary Tumor Models

(2012) S. M. Dunlap et al.   Cancer Prevention Research

Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles

(2012) Dharmika S.P. Lansakara-P. et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001

(2012) Rebecca E. De Angel et al.   MOLECULAR CARCINOGENESIS

Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells

(2012) R S Price et al.   PROSTATE CANCER AND PROSTATIC DISEASES

The growing challenge of obesity and cancer: an inflammatory issue

(2011) Alison E. Harvey et al.   Annals of the New York Academy of Sciences

Inflammatory Talk: Linking Obesity, NF- B, and Aromatase

(2011) S. D. Hursting   Cancer Prevention Research

Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland

(2011) K. Subbaramaiah et al.   Cancer Prevention Research

Nanomedicine in cancer therapy: Innovative trends and prospects

(2011) Elvin Blanco et al.   CANCER SCIENCE

Implications of Obesity for Drug Therapy: Limitations and Challenges

(2011) R Jain et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

(2011) Brian R. Sloat et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity

(2011) Michael A. Sandoval et al.   JOURNAL OF CONTROLLED RELEASE

Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1

(2011) Woon-Gye Chung et al.   JOURNAL OF CONTROLLED RELEASE

Other Options in the Treatment of Advanced Breast Cancer

(2011) Melody A. Cobleigh   SEMINARS IN ONCOLOGY

Nanoparticulate Alternatives for Drug Delivery

(2010) James H. Adair et al.   ACS Nano

P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis

(2010) Robin Fuchs-Young et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

(2010) Melinda Protani et al.   BREAST CANCER RESEARCH AND TREATMENT

Delivering nanomedicine to solid tumors

(2010) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice

(2010) James W. Behan et al.   PHARMACOLOGICAL RESEARCH

Adipocytes Impair Leukemia Treatment in Mice

(2009) J. W. Behan et al.   CANCER RESEARCH

Obesity and Breast Cancer: The Estrogen Connection

(2009) Margot P. Cleary et al.   ENDOCRINOLOGY

Therapeutic Nanoparticles for Drug Delivery in Cancer

(2008) K. Cho et al.   CLINICAL CANCER RESEARCH

Obesity and Cancer Treatment: Weighing the Evidence

(2008) Jennifer J. Griggs et al.   JOURNAL OF CLINICAL ONCOLOGY

New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine

(2008) S. A. Veltkamp et al.   MOLECULAR CANCER THERAPEUTICS

Obesity Accelerates Mouse Mammary Tumor Growth in the Absence of Ovarian Hormones

(2008) Nomelí P. Núñez et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL